home / stock / acst / acst quote
Last: | $3.04 |
---|---|
Change Percent: | 0.0% |
Open: | $3.03 |
Close: | $3.04 |
High: | $3.15 |
Low: | $3.0101 |
Volume: | 8,569 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.04 | $3.03 | $3.04 | $3.15 | $3.0101 | 8,569 | 07-16-2024 |
$3.03 | $3.12 | $3.03 | $3.16 | $3.01 | 17,551 | 07-15-2024 |
$3.12 | $2.98 | $3.12 | $3.17 | $2.98 | 7,531 | 07-12-2024 |
$3.03 | $3.1 | $3.03 | $3.1 | $3.02 | 12,573 | 07-11-2024 |
$3.07 | $3.01 | $3.07 | $3.19 | $2.9757 | 21,849 | 07-10-2024 |
$3.06 | $2.77 | $3.06 | $3.07 | $2.77 | 14,881 | 07-09-2024 |
$2.85 | $2.85 | $2.85 | $2.95 | $2.77 | 11,487 | 07-08-2024 |
$2.8896 | $2.842 | $2.8896 | $2.8896 | $2.79 | 2,430 | 07-05-2024 |
$2.9 | $2.82 | $2.9 | $3.07 | $2.82 | 14,122 | 07-04-2024 |
$2.9 | $2.82 | $2.9 | $3.07 | $2.82 | 14,122 | 07-03-2024 |
$2.85 | $2.87 | $2.85 | $3.05 | $2.81 | 6,681 | 07-02-2024 |
$2.92 | $2.89 | $2.92 | $2.92 | $2.81 | 8,245 | 07-01-2024 |
$2.92 | $2.97 | $2.92 | $3.055 | $2.22 | 86,403 | 06-28-2024 |
$2.97 | $2.93 | $2.97 | $3.03 | $2.85 | 8,496 | 06-27-2024 |
$2.96 | $3.08 | $2.96 | $3.08 | $2.92 | 7,589 | 06-26-2024 |
$3.1 | $3.1144 | $3.1 | $3.2 | $3.1 | 13,831 | 06-25-2024 |
$3.2 | $3.24 | $3.2 | $3.24 | $3.1411 | 7,509 | 06-24-2024 |
$3.3 | $3.15 | $3.3 | $3.3 | $3.09 | 26,065 | 06-21-2024 |
$3.15 | $3.29 | $3.15 | $3.3 | $3.06 | 18,593 | 06-20-2024 |
$3.2922 | $3.26 | $3.2922 | $3.32 | $3.2 | 19,316 | 06-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
PRINCETON, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemor...
Patient Enrollment in Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 On-Track for Potential NDA Submission in 1H Calendar 2025 Projected Cash Runway into Second Calendar Quarter 2026 PRINCETON, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (...